Hypokalemic Periodic Paralysis Induced by Factitious Hyperthyroidism for Weight Reduction.

Kobayashi T, Ono Y, Hirooka N

Resectable Pancreatic Cancer with CA19-9 > 500Â U/mL: A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy.

Omiya K, Oba A, Sugiura K, Maekawa A, Mie T, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Inoue Y, Takahashi Y

ASO Visual Abstract: Resectable Pancreatic Cancer with CA19-9 > 500 U/mL-A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy.

Omiya K, Oba A, Sugiura K, Maekawa A, Mie T, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Inoue Y, Takahashi Y

Self-Limiting Steroid-Induced Acute Pancreatitis.

Kaneko R, Ono Y, Hirooka N

ASO Author Reflections: Optimizing Treatment for Resectable Pancreatic Cancer: CA19-9 > 500 U/mL as a Biologic Indicator for Neoadjuvant Therapy.

Omiya K, Oba A, Sugiura K, Maekawa A, Mie T, Kobayashi K, Ono Y, Ito H, Inoue Y, Takahashi Y

Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials.

Panaccione R, Feagan BG, Afzali A, Rubin DT, Reinisch W, Panés J, Danese S, Hisamatsu T, Terry NA, Salese L, Van Rampelbergh R, Sahoo A, Vetter ML, Yee J, Han C, Frustaci ME, Wan KYY, Yang Z, Johanns J, Andrews JM, D'Haens GR, Sands BE, GALAXI 2 & 3 Study Group

ASO Author Reflections: Diabetic and Nutritional Management After Total or Completion Pancreatectomy: Current Status and Future Perspectives.

Kato T, Ono Y, Kitazawa T, Kobayashi K, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y

Impact of Polymerase Acidic Subunit (PA) Substitutions on Fever and Symptoms in Pediatric Influenza A Patients Treated with Baloxavir: A Pooled Four-Season Analysis.

Saito R, Chon I, Sato I, Kawashima T, Kakuya F, Saito T, Minato M, Kodo N, Suzuki E, Ono Y, Masaki H, Asou N, Tsuchihashi Y, Shirahige Y, Kitano A, Shimada Y, Hamabata H, Li J, Sun Y, Lee N, Wagatsuma K, Ichikawa Y, Prunama TB, Tamura T, Watanabe H

Association Between Preoperative Penile Circumference and Urinary Function After Robot-Assisted Radical Prostatectomy.

Kohada Y, Kitano H, Tasaka S, Ono Y, Tasaka R, Miyamoto S, Hatayama T, Shikuma H, Takemoto K, Naito M, Kobatake K, Sekino Y, Goto K, Goriki A, Hieda K, Hinata N

Urinary β2-microglobulin as a Potential Biomarker for Early Treatment Selection: A Patient with Severe IgG4-related Tubulointerstitial Nephritis.

Taniguchi N, Sakai M, Masuda T, Otsuki C, Asakura-Kinoshita M, Misawa K, Oe K, Ono K, Wakabayashi N, Oka K, Hishida E, Ono Y, Akimoto T, Nagata D

Uterine angle changes during the in vitro fertilization treatment cycle.

Yoshihara T, Ogi M, Ono Y, Miyashita D, Tanaka K, Tada Y, Ogawa T, Fukuda T, Okuda Y, Yoshino O

Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resectable pancreatic cancer : Outcomes and prognostic radiotherapeutic factors.

Iwai T, Yoshimura M, Ono Y, Ogawa A, Ashida R, Masui T, Nagai K, Anazawa T, Kasai Y, Yamane K, Hatano E, Kanai M, Fukuda A, Isoda H, Mizowaki T

Brain atrophy patterns in anti-IgLON5 disease.

Yogeshwar SM, Bartels F, GrĂźter T, MuĂąiz-Castrillo S, Picard G, Crijnen YS, Bernard E, Heidbreder A, Zekeridou A, Ringelstein M, Kraft A, Kovac S, Wandinger KP, de Vries JM, Boon AJW, Veenbergen S, Geis C, Penner L, Melzer N, Leypoldt F, Blaabjerg M, Pittock SJ, Gaig C, Sabater L, Santamaria J, Graus F, Dalmau J, PrĂźss H, HĂśftberger R, Schreiner B, McKeon A, Lewerenz J, Irani S, Mignot E, Titulaer MJ, Ayzenberg I, Honnorat J, Finke C, IgLON5 Imaging Consortium

Impact of Preoperative Diabetes on Insulin Management and Nutritional Status After Total or Completion Pancreatectomy.

Kato T, Ono Y, Kitazawa T, Kobayashi K, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y

Distinct systemic metabolic features in limb-girdle muscular dystrophy type R1 mouse models as a potential early pathogenic signature.

Shinkai-Ouchi F, Itoh Y, Shindo M, Mikami K, Iguchi Y, Hata S, Tsutsumi R, Izumi-Mishima Y, Machida K, Suzuki Y, Sakaue H, Ono Y